Science needs to overcome “structural racism” to end the HIV epidemic
A new report published in The Lancet investigates why 43% of HIV deaths in 2018 happened in the Black community, with policy solutions for the ongoing HIV epidemic.
Humanitarian Engineering: Co-creating with communities
The Humanitarian Engineering Program at the Colorado School of Mines teaches engineers to work as partners with society.
Technology solutions for the aquaculture sector
Carlos Mazorra, Director of Innovation and Enrique Amaré, CEO of SMARTWATER PLANET share with us their thoughts on affordable technology solutions for the aquaculture sector.
University challenge: Remote cash recovery
Rockford Associates Limited walks us through a challenge for Royal Holloway – University of London, remote cash recovery.
New Zealand will give free menstrual products to decrease period poverty
Prime Minister Jacinda Ardern is going to implement a new policy - students will receive free menstrual products from June, to decrease the period poverty that limits access to education.
Advice for first time buyers ahead of the new financial year
Kier Living break down some of the crucial details that first time buyers need to consider before buying a home ahead of the new financial year.
Hong Kong approves the Sinovac COVID vaccine for use
The Sinovac COVID vaccine was revealed to be working at 50.4% efficacy by the Butantan Institute last month, but new data suggests that this could actually be 62%.
UK government to launch new high risk research agency
The UK government will launch a new independent research body to fund high-risk, high-reward scientific research called the Advanced Research & Invention Agency (ARIA).
Can employers legally enforce compulsory vaccination on their workers?
Debbie Sadler, senior associate on the employment team at Blaser Mills Law, discusses whether or not employers are legally entitled to enforce compulsory COVID-19 vaccination on their workers.
NASA’s Perseverance rover successfully lands on Mars
NASA’s Perseverance rover will make its final descent to Mars on the 18th of February 2021 at approximately 12:55 p.m. PST.
The spike mutation makes COVID eight times more infectious
The spike protein mutation found in the Brazilian, South African and UK variants of COVID-19 can make the virus eight times more infectious.
Irregular sleep schedule increases risk of depression
A new study has found that having an irregular sleep schedule can increase the risk of bad moods and depression.
Student nurse applications increase by one third in 2021
After COVID-19 hit the NHS, the public health crisis highlighted the poignant and essential nature of nursing work - leading to student nurse applications increasing to 60,130 for 2021.
New research studies to tackle Long COVID in the community
Four new research studies looking into Long COVID in the community will receive funding worth £18.5 million from UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR).
Can an mRNA vaccine be used to cure some types of cancer?
COVID brought the idea of mRNA vaccines to the attention of the world - now, cancer researchers are investigating how a similar vaccine could stop tumours in a single treatment.
Pfizer vaccine can still prevent death from the South African mutation
The Pfizer and BioNTech vaccine appears to be significantly less efficient against the South African mutation, but can still stop hosts from experiencing severe COVID and dying from the virus.
NASA’s Perseverance rover searches for life on Mars
NASA's Perservance rover will begin its descent to Mars today (18th February) in search of microbial life on the Red Planet.
REACT study: COVID cases in hospitals “higher than at the peak of the first...
New data from the REACT study finds that the number of COVID cases in hospitals is higher than it was in April 2020, but that infection rates are substantially decreasing across the country.
UK receives ethics approval for first coronavirus human challenge study
The UK has received approval from the clinical trials ethics body for the world's first coronavirus human challenge study.
European Commission approves second Moderna contract for 300m vaccines
The European Commission has approved a second contract with Moderna to secure an additional 300 million vaccine doses.
